Login / Signup

Drug-coated balloon for early recurrent arteriovenous fistula dysfunction.

Chun-Hsien HsinHsuan-Tzu YangPin-Chao FengTa-Wei SuSheng-Yueh YuPo-Jen Ko
Published in: The journal of vascular access (2023)
The results demonstrated the appliance of Ranger DCB in stenotic AVFs is a safe and effective treatment modality, especially for early recurrent AVF stenosis.
Keyphrases
  • oxidative stress
  • adverse drug
  • electronic health record